Form 4: Pfizer Executive Rady A. Johnson Reports Acquisition of Phantom Stock Units

Executive Vice President Rady A. Johnson reports acquiring phantom stock units in Pfizer through the Supplemental Savings Plan.

Summary

• Rady A. Johnson, an Executive Vice President at Pfizer Inc., filed a Form 4 with the SEC.
• The filing reports the acquisition of 6 phantom stock units on October 15, 2024, at a price of $29.44 per unit.
• These units were acquired through the Pfizer Supplemental Savings Plan (SSP).
• Johnson directly owns 9,189 derivative securities following the reported transaction.
• The phantom stock units are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing, reporting a standard transaction. It doesn't inherently convey positive or negative sentiment.

Positives

• The acquisition of phantom stock units aligns the executive's interests with the company's performance.
• The Supplemental Savings Plan provides a mechanism for executives to save and invest in company stock.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Stakeholder Impact

• The filing provides transparency to shareholders regarding executive compensation and ownership.

Key Dates